IP Library Granted Patent US 10,194,645
Granted Patent B2
US 10,194,645 · App. 15/230,564 · Granted Feb 5, 2019

Mouse λ light chain locus

Inventors: Marianne Brüggemann (Cambridge, GB); Xiangang Zou (Cambridge, GB)
Assignee: Crescendo Biologics Limited
A01K67/0276C07K16/00C07K16/06A01K2217/058A01K2217/075A01K2227/105A01K2267/01C07K2317/56C12N2800/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,194,645
App. No.
15/230,564
Granted
Feb 5, 2019
Kind
B2
Abstract

The present invention provides in a first aspect a mouse in which the λ (lambda) light chain locus has been functionally silenced. In one embodiment, the mouse λ light chain locus was functional silenced by deletion of gene segments coding for the λ light chain locus. In a further aspect, a mouse containing functionally silenced λ and κ (kappa) L chain loci was produced. The invention is useful for the production of antibodies, for example heterologous antibodies, including heavy chain only antibodies.

Claims (15)

1. A knock-out mouse comprising one or more deletions that functionally silence the immunoglobulin lambda light chain locus of the knock-out mouse, wherein the one or more deletions that functionally silence the immunoglobulin lambda light chain locus of the knock-out mouse consist of:

(a) a deletion of lambda light chain genes C2 and C3-C1; or

(b) a deletion of lambda light chain genes C2, C4, C3 and C1,

wherein the lambda light chain locus is not deleted completely.

2. The knock-out mouse according to claim 1 , wherein the mouse immunoglobulin κ light chain locus is functionally silenced by targeted integration of a selectable marker gene in Cκ or targeted deletion of Cκ or Jκ.

3. The knock-out mouse according to claim 1 , wherein the mouse immunoglobulin heavy chain locus is functionally silenced by targeted integration of a selectable marker gene in the μ membrane exons or targeted deletion of the JH gene segments.

4. The knock-out mouse according to claim 1 , wherein the knock-out mouse comprises one or more heavy and/or a light chain immunoglobulin genes or loci from a human.

5. The knock-out mouse according to claim 2 , wherein the mouse immunoglobulin heavy chain locus is functionally silenced by targeted integration of a selectable marker gene in the μ membrane exons or targeted deletion of the JH gene segments.

6. A method comprising the steps of:

(a) providing a knock-out mouse according to claim 1 , wherein the mouse immunoglobulin κ light chain locus is functionally silenced by targeted integration of a selectable marker gene in Cκ or targeted removal of Cκ or Jκ and wherein the mouse immunoglobulin heavy chain locus is functionally silenced by targeted integration of a selectable marker gene in the μ membrane exons or targeted deletion of the JH gene segment; and

(b) introducing into said knock-out mouse at least one transgene which comprises one or more immunoglobulin heavy genes or loci from a heterologous species wherein the heterologous species is human.

7. A method for making a library of VH domains comprising

(a) providing a knock-out mouse of claim 1 wherein the mouse immunoglobulin κ light chain locus is functionally silenced by targeted integration of a selectable marker gene in Cκ or targeted removal of Cκ or Jκ and wherein the mouse immunoglobulin heavy chain locus is functionally silenced by targeted integration of a selectable marker gene in the μ membrane exons or targeted deletion of the JH gene segment;

(b) introducing into said knock-out mouse at least one transgene which comprises one or more immunoglobulin heavy chain genes or loci from a heterologous species wherein the heterologous species is human; and

(c) preparing a library of VH domains from DNA of lymphocytes from said knock-out mouse.

Assignments (3)
CHANGE OF NAME Recorded Nov 14, 2016
From: TRANSLOCUS LIMITED
To: CRESCENDO BIOLOGICS LIMITED
Reel/Frame 040311/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2016
From: BRUGGEMANN, MARIANNE; ZOU, XIANGANG
To: THE BABRAHAM INSTITUTE
Reel/Frame 040311/0132 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2016
From: BABRAHAM INSTITUTE
To: TRANSLOCUS LIMITED
Reel/Frame 040311/0157 →
Continuity (4)
Continuation 13654007 · Oct 17, 2012
Continuation 12476087 · Jun 1, 2009
Continuation 10481395
Related Publication 20170049083A1 · Feb 23, 2017